Abstract
New Clinical Initiatives at the Steno Diabetes Center Odense and in the Region of Southern Denmark
Highlights
The Danish physician Hans Christian Hagedorn (1888-1971) initiated the industrial production of insulin in Denmark in 1923 together with the Danish physiologist August Krogh (1874-1949) by founding the company Nordisk Insulin Laboratorium, which much later merged into the pharmaceutical company Novo Nordisk A/S [1]
Further in 1936, Hans Christian Hagedorn co-discovered the principle of addition of protamine to insulin, in order to protract its time of action [2]
The initial idea of Nordisk Insulin Laboratorium was to ensure the availability of insulin for the patients, and to support research, treatment and care of patients with diabetes
Summary
Michael E Røder*, Maria Skovlund Herreborg and Jan Erik Henriksen Steno Diabetes Center Odense, Odense University Hospital, Denmark *Corresponding author: Michael E Røder, Associate Professor, Steno Diabetes Center Odense, Odense University Hospital, Denmark
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
